salicylic acid has been researched along with Breast Neoplasms in 174 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 20 min PICT is as effective as 45 and 90 min to prevent weekly paclitaxel-induced alopecia and should be the new standard of care." | 9.51 | Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial. ( Deursen, MAGDH; Gelderblom, H; Houtsma, D; Kaptein, AA; Kroep, JR; Lugtenberg, RT; Mosch, L; Smorenburg, CH; van den Hurk, CJG, 2022) |
| "The objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metastatic or unresectable angiosarcoma." | 9.13 | Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. ( Bay, JO; Blay, JY; Bompas, E; Brain, EG; Bui, BN; Chevreau, C; Cupissol, D; Fournier, C; Isambert, N; Jimenez, M; Kerbrat, P; Penel, N; Peyrade, F; Piperno-Neumann, S; Ray-Coquard, I; Taieb, S, 2008) |
| "We analyzed 68 female Japanese patients with breast cancer (median age 53 years, range 29-76 years) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane." | 8.02 | Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients. ( Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R, 2021) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 8.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| " In this study, the effects of methylene blue-curcumin (CU-MB) and methylene blue-salicylic acid (SA-MB) ion pair complexes on MDA-MB-231 human breast cancer cells are studied." | 7.91 | Comparative study of photodynamic activity of methylene blue in the presence of salicylic acid and curcumin phenolic compounds on human breast cancer. ( Chamani, E; Hosseinzadeh, G; Hosseinzadeh, R; Khorsandi, K, 2019) |
| "A 20 min PICT is as effective as 45 and 90 min to prevent weekly paclitaxel-induced alopecia and should be the new standard of care." | 5.51 | Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial. ( Deursen, MAGDH; Gelderblom, H; Houtsma, D; Kaptein, AA; Kroep, JR; Lugtenberg, RT; Mosch, L; Smorenburg, CH; van den Hurk, CJG, 2022) |
| "Chemotherapy for breast cancer induces alopecia, representing a major source of patient distress." | 5.48 | Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy. ( Schoenegg, W; Vasconcelos, I; Wiesske, A, 2018) |
| "It was suspected that breast cancer could be metastasized to the scalp, but mammography, ultrasound, and positron emission tomography showed no particular metastases in her breast and other organs." | 5.37 | [A case of scalp metastases from breast cancer successfully treated with letrozole]. ( Ishiba, T; Kubota, K; Kuwayama, T; Nakagawa, T; Sato, T; Sugihara, K; Sugimoto, H, 2011) |
| "Randomized controlled trials (RCT) of scalp cooling (SC) to prevent chemotherapy induced alopecia (CIA) did not evaluate its effect on hair regrowth (HR) and was conducted in a predominantly taxane (T) treated population." | 5.34 | "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia". ( Bajpai, J; Banavali, SD; Chandrasekharan, A; Dandekar, S; Ghosh, J; Gupta, S; Kagwade, S; Kanan, S; Kembhavi, Y, 2020) |
| "Brain metastases from breast cancer have a poor prognosis." | 5.33 | Letrozole for brain and scalp metastases from breast cancer--a case report. ( Bhatt, ML; Kirti, S; Kumar, S; Madhup, R; Srivastava, M; Srivastava, PK, 2006) |
| "Among women with stage I to II breast cancer receiving chemotherapy with a taxane, anthracycline, or both, those who underwent scalp cooling were significantly more likely to have less than 50% hair loss after the fourth chemotherapy cycle compared with those who received no scalp cooling." | 5.24 | Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. ( Abraham, J; Courtright, J; Hilsenbeck, S; Holmes, F; Lacouture, M; Nangia, J; Niravath, P; Osborne, C; Osborne, CK; Otte, K; Papish, S; Paxman, R; Rimawi, M; Rude, M; Wang, T, 2017) |
| "The objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metastatic or unresectable angiosarcoma." | 5.13 | Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. ( Bay, JO; Blay, JY; Bompas, E; Brain, EG; Bui, BN; Chevreau, C; Cupissol, D; Fournier, C; Isambert, N; Jimenez, M; Kerbrat, P; Penel, N; Peyrade, F; Piperno-Neumann, S; Ray-Coquard, I; Taieb, S, 2008) |
| "The applicability and efficacy of a scalp cooling system were studied in 105 breast cancer patients receiving four cycles of adjuvant chemotherapy with mitoxantrone + cyclophosphamide (NC chemotherapy)." | 5.10 | Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. ( Camerlo, J; d'Ingrado, MP; Evans, K; Genre, D; Macquart-Moulin, G; Maraninchi, D; Protière, C; Viens, P, 2002) |
| "We report the case of a 70-year-old woman affected by breast cancer in treatment with Palbociclib, who developed alopecia." | 4.02 | A new treatment of alopecia induced by palbociclib: Topical cetirizine. ( Carlesimo, M; Caro, G; Federico, A; Fortuna, MC; Magri, F; Rossi, A, 2021) |
| "We analyzed 68 female Japanese patients with breast cancer (median age 53 years, range 29-76 years) who received perioperative adjuvant chemotherapy with fluorouracil/epirubicin/cyclophosphamide (FEC) and taxane." | 4.02 | Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients. ( Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R, 2021) |
| " In this study, the effects of methylene blue-curcumin (CU-MB) and methylene blue-salicylic acid (SA-MB) ion pair complexes on MDA-MB-231 human breast cancer cells are studied." | 3.91 | Comparative study of photodynamic activity of methylene blue in the presence of salicylic acid and curcumin phenolic compounds on human breast cancer. ( Chamani, E; Hosseinzadeh, G; Hosseinzadeh, R; Khorsandi, K, 2019) |
| "A prospective cohort study conducted at 5 US medical centers of women with stage I or II breast cancer receiving adjuvant or neoadjuvant chemotherapy regimens excluding sequential or combination anthracycline and taxane (106 patients in the scalp cooling group and 16 in the control group; 14 matched by both age and chemotherapy regimen)." | 3.85 | Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. ( Bågeman, E; Cigler, T; D'Agostino, RB; Esserman, L; Hurvitz, SA; Klein, P; Melin, SA; Melisko, ME; Mitchel, J; Moore, A; Park, G; Rugo, HS; Ver Hoeve, ES, 2017) |
| "Apoptosis is induced in MCF-7 breast cancer cells following treatment with salicylic acid (20 mM), either in the presence or absence of a heat shock (42°C for 30 min)." | 3.78 | Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells. ( Cronjé, MJ; Ferreira, E, 2012) |
| "With current adjuvant chemotherapy for breast cancer, in which a combination of cyclophosphamide and an anthracycline is often used, there is no place for scalp hypothermia." | 3.77 | Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. ( Liefers, GJ; Repelaer van Driel, OJ; Tollenaar, RA; van de Velde, CJ, 1994) |
| "Forty women with early breast cancer were randomly assigned to EHW (n = 20) or observation (n = 20) during neo(adjuvant) chemotherapy." | 3.30 | Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study. ( Almeida, P; Bomfim, VHV; Costa E Silva, M; da Silva, CF; de Castro, ALR; de Cerqueira Mathias, CM; de Oliveira Dantas Viana, P; Dienstmann, R; Dos Santos, APT; Freitas Muniz Teixeira, A; Jamile Santiago Costa, M; Landeiro, LCG; Lopes Paim Miranda, D; Mathias Machado, R; Teixeira Machado, B; Viviane Carvalho Rodrigues Gonçalves, M, 2023) |
| "One hundred six eligible breast cancer patients were randomly distributed into a low-level light therapy group and a control group, after receiving chemotherapy." | 3.30 | The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial. ( Chang, ZY; Cheng, HY; Lee, CH; Li, CH; Shiao, YH; Wu, CX; Wu, TH; Yeh, YC, 2023) |
| "Catiana Martinez Cánovas of the Spanish Breast Cancer Federation [FECMA]) participated in the review of the study protocol, as well as in the results, discussion and conclusions, making their contributions." | 3.01 | Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review. ( Del Mar Trujillo-Martín, M; Delgado Rodríguez, J; Infante-Ventura, D; Ramos-García, V; Rueda-Domínguez, A; Serrano-Aguilar, P; Suarez-Herrera, JC, 2023) |
| "The main outcome measure was alopecia (hair loss>50%) during and after chemotherapy treatment." | 3.01 | [Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.] ( Abt-Sack, A; de Armas-Castellano, A; Del Pino-Sedeño, T; González-Hernández, Y; González-Pacheco, H; Infante-Ventura, D; Ramallo-Fariña, Y; Rueda Domínguez, A; Serrano-Aguilar, P; Trujillo-Martín, MM, 2023) |
| "Some studies reported a reduction of hair loss with the use of the scalp cooling device." | 2.90 | Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience. ( Andreis, F; Huscher, A; Mirandola, M; Mutti, S; Pedrali, C; Pomentale, B; Prochilo, T; Zaina, E; Zaniboni, A; Zanotti, L, 2019) |
| "Main reasons for drop-out were hair loss, adverse events (CAP), and randomization into control arm." | 2.90 | COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. ( Feißt, M; Hassel, JC; Heil, J; Hennigs, A; Jaeger, D; Junio, P; Marmé, F; Matthies, LM; Mayer, L; Schneeweiss, A; Schumann, A; Seitz, J; Smetanay, K; Sohn, C, 2019) |
| "Hair loss was assessed by patients using a 100-point Visual Analog Scale (VAS) and by physicians using the 5-point Dean Scale at baseline, every 3-4 weeks during chemotherapy, and at least 1 month after completion of chemotherapy." | 2.87 | Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. ( DeLuca, AN; Esserman, LJ; Melisko, ME; Rice, BA; Rugo, HS; Ver Hoeve, ES, 2018) |
| "Chemotherapy-induced hair loss in cancer is usually temporary but can take a significant emotional toll on patients and lead to treatment refusal in many cases." | 2.82 | Chemotherapy, Alopecia, and Scalp Cooling Systems. ( Amarillo, D; Cuello, M; de Boni, D, 2022) |
| "Chemotherapy-induced hair loss is perceived as burdensome." | 2.74 | Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. ( Breed, WP; Mols, F; van den Hurk, CJ; Vingerhoets, AJ, 2009) |
| "Failure to prevent hair loss in patients undergoing an expensive and potentially uncomfortable treatment likely contributes to decreased well-being, impacting the overall distribution of QoL measures in scalp cooling patients compared to controls." | 2.61 | The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. ( Hagigeorges, D; Isakoff, SJ; Lacouture, ME; Manatis-Lornell, AJ; Marks, DH; Okhovat, JP; Senna, MM, 2019) |
| "Most were patients with breast cancer 432 patients [66%] mainly receiving anthracyclines." | 2.58 | Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Rugo, HS; Voigt, J, 2018) |
| "Myoepitheliomas are typically benign tumours arising from exocrine glands." | 2.42 | Metastatic myoepithelioma of the breast. ( Gonzales, M; Jennens, RR; Rosenthal, MA, 2004) |
| "A woman with no previous history of breast carcinoma presented with focal hair loss, which was presumptively diagnosed as alopecia areata." | 2.39 | Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma. ( Carson, HJ; Lack, E; Pellettiere, EV, 1994) |
| "Thirty-nine breast cancer patients who underwent anthracycline- and/or taxane-based chemotherapy were assigned to the scalp cooling group(27 patients)and the hair loss observation group(12 patients)." | 1.91 | [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients]. ( Fukuma, E; Kato, M; Nomizu, T; Ueo, H, 2023) |
| "While breast cancer is the most common cancer in women, cutaneous metastases are rare in breast cancer." | 1.91 | Breast cancer with scalp metastases: a case report. ( Abdulraheem, AM; Al Heyasat, AN; Alhasan, M; Almasri, NM; Naji, D; Odeh, R, 2023) |
| "Treatment-induced alopecia is a common concern among women preparing for chemotherapy." | 1.72 | Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study. ( Jackson, K; Krishnasamy, M; Renehan, S; Tencic, M, 2022) |
| "We prospectively monitored cancer patients from August 2017 to October 2019 receiving oncological treatments with SC, using the sensor-controlled system "DigniCap." | 1.72 | Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany. ( Ebner, F; Hempel, D; Hempel, L; Keim, S; Milani, V; Retzer-Lidl, M; Wohlmuth, K, 2022) |
| " Most adverse effects were mild and moderate, and scalp cooling did not increase the risk of scalp metastases." | 1.72 | Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia. ( Huang, J; Liu, WQ; Ning, N; Yang, KL; Zhang, XY, 2022) |
| "Breast cancer is the most familiar solid tumor analyzed in women." | 1.72 | Interaction Between Essential (Zn) and Toxic (Cd) Elements in Different Stages of Female Breast Cancer Patients, Resident in Different Cities of Sindh, Pakistan. ( Afridi, HI; Baig, JA; Chanihoon, GQ; Kazi, TG; Talpur, FN, 2022) |
| "Hair loss was assessed using the Dean scale, where a score of 0-2 (hair loss ≤50%) was defined as successful." | 1.62 | Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device. ( Amoroso, V; Ardine, M; Berruti, A; Bianchi, S; Conti, E; Cosentini, D; Dalla Volta, A; di Mauro, P; Fornaro, C; Gelmi, M; Motta, P; Pedersini, R; Pierini, M; Rodella, F; Simoncini, EL; Turla, A; Vassalli, L, 2021) |
| "Alopecia was assessed by trained oncology providers using the modified Dean scale (MDS) prior to each chemotherapy session." | 1.62 | Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer? ( Adams-Campbell, L; Alintah, P; Chitalia, A; Dash, C; Dilawari, A; Gallagher, C; Paxman, R; Tiwari, S, 2021) |
| "Female Japanese breast cancer patients who planned to receive (neo)adjuvant chemotherapy participated in this prospective study on the efficacy of scalp cooling using the Paxman Scalp Cooling System for alopecia prevention." | 1.62 | Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy. ( Aogi, K; Doi, M; Hara, F; Kiyoto, S; Matsuda, M; Ohsumi, S; Takahashi, M; Takashima, S; Yamamura, N, 2021) |
| "Scalp metastasis from breast cancer is an exceedingly infrequent phenomenon." | 1.56 | An Unusual Case of Scalp Metastasis from Breast Cancer. ( Li, J; Li, T; Liu, LY; Liu, YF; Xia, SL, 2020) |
| "The eccrine carcinoma is a rare form of skin adnexal malignancy, usually presenting as a locally invasive, solitary lesion in the head and neck region." | 1.56 | [Eccrine carcinoma: a diagnostic pitfall]. ( Hoven-Gondrie, ML; Koot, RAC; Moonen, HPFX, 2020) |
| "Consecutive early breast cancer patients admitted to Istituto Oncologico Veneto who were recommended to receive neoadjuvant or adjuvant CT, were eligible to undergo scalp cooling during the CT administration within this study." | 1.56 | Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. ( Di Liso, E; Dieci, MV; Faggioni, G; Falci, C; Frezzini, S; Giarratano, T; Giorgi, CA; Griguolo, G; Grosso, D; Guarneri, V; Mantiero, M; Menichetti, A; Miglietta, F; Mioranza, E; Tasca, G; Vernaci, G; Zanocco, M, 2020) |
| "Many breast cancer patients suffer from chemotherapy-induced hair loss." | 1.51 | A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. ( Hasegawa, Y; Imai, H; Nozawa, K; Ohashi, Y; Okada, H; Saito, M; Sangai, T; Shimozuma, K; Takayama, T; Tamai, N; Watanabe, T; Yagata, H; Yajima, T; Yamaguchi, T; Yoshida, Y; Yoshimura, A, 2019) |
| "Chemotherapy-induced alopecia (CIA) is a distressing side effect of cancer therapy." | 1.51 | Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. ( Bagnardi, V; Bianco, N; Campennì, G; Cancello, G; Cardillo, A; Colleoni, M; Dellapasqua, S; Iorfida, M; Masiero, M; Mazza, M; Mazzocco, K; Montagna, E; Munzone, E; Pagan, E; Palazzo, A; Pettini, G; Pravettoni, G; Sangalli, C; Tramacere, A; Veronesi, P, 2019) |
| "Chemotherapy for breast cancer induces alopecia, representing a major source of patient distress." | 1.48 | Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy. ( Schoenegg, W; Vasconcelos, I; Wiesske, A, 2018) |
| "Patients reported degree of hair loss using the Dean score on day 1 of each cycle and following the last chemotherapy." | 1.48 | Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. ( Bauwens, A; Chan, A; Chih, J; Ernenwein, T; Jackson, S; McGlone, F; Pontre, S; Reid, C, 2018) |
| "We concluded on the diagnosis of scalp dermatofibrosarcoma protuberans with breast metastasis and probable pleuropulmonary metastasis." | 1.46 | Breast and pleuropulmonary metastasis of multirecurrent scalp dermatofibrosarcoma protuberans: a case report. ( Bambara, HA; Lamien/Sanou, A; Ouédraogo Nde, NA; Ouédraogo, MS; Ouédraogo, NA; Tapsoba, GP; Thouraya Chtioui, A; Tiemtoré-Kambou, BM; Traoré, F; Zongo, N, 2017) |
| "More than 75% of patients with cancer cite alopecia as the most feared side effect of treatment, with as many as 10% considering treatment refusal." | 1.46 | Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia . ( Fischer-Cartlidge, E; Ross, M, 2017) |
| "Chemotherapy-induced hair loss is a common and distressing side effect." | 1.43 | Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. ( Andrews, K; Baylock, B; Boyle, F; O'Reilly, A; Pugliano, L; Shaw, J; Winstanley, J, 2016) |
| "Its efficacy in angiosarcoma has not been investigated." | 1.43 | Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study. ( Bonadies, A; Bucher, S; Cabula, C; Campana, LG; Curatolo, P; Grilz, G; Guida, M; Rossi, CR; Rotunno, R; Santoriello, A; Solari, N; Strippoli, S; Valpione, S, 2016) |
| "Degree of hair loss was assessed by a single practitioner using Dean's alopecia scale (grade 1/excellent [< 25% hair loss], grade 2/good [25%-50% hair loss], grade 3/moderate [50%-75% hair loss], grade 4/poor [> 75% hair loss]), by digital photographs, and by patient self-report of hair thinning or the need to wear a wig/head covering, or both." | 1.42 | Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy. ( Chuang, E; Cigler, T; Fiederlein, B; Isseroff, D; Moore, A; Schneider, S; Vahdat, L, 2015) |
| "Two cases of breast cancer with scalp metastases as first metastatic site are presented." | 1.37 | Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up. ( Desbiens, C; Hogue, JC; Lemieux, J, 2011) |
| "It was suspected that breast cancer could be metastasized to the scalp, but mammography, ultrasound, and positron emission tomography showed no particular metastases in her breast and other organs." | 1.37 | [A case of scalp metastases from breast cancer successfully treated with letrozole]. ( Ishiba, T; Kubota, K; Kuwayama, T; Nakagawa, T; Sato, T; Sugihara, K; Sugimoto, H, 2011) |
| "The incidence of scalp metastases and the disease course were studied in 885 very well evaluated high-risk breast cancer patients." | 1.36 | [Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur]. ( Breed, WP; Nortier, JW; van de Sande, MA; van den Hurk, CJ, 2010) |
| "Alopecia neoplastica is defined as hair loss secondary to a visceral malignancy that has metastasized to the scalp." | 1.35 | Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica. ( Cohen, PR; Conner, KB, 2009) |
| "Malignant skin cancer of the scalp with skull invasion, dural infiltration and brain involvement is a uncommon lesion." | 1.35 | Aggressive scalp carcinoma with intracranial extension: a multidisciplinary experience of 25 patients with long-term follow-up. ( Catania, V; Chibbaro, S; Diemidio, P; Fricia, M; Makiese, O; Marsella, M; Passanisi, M; Siragò, P; Soma, PF; Ventura, F, 2008) |
| "Pigmented metastases of a breast carcinoma have rarely been described in the literature and these metastases are usually located on the chest and abdominal wall close to the mastectomy scar." | 1.35 | Cutaneous metastasis of breast carcinoma mimicking malignant melanoma in scalp. ( García, L; Jordá, E; López, V; Martí, N; Molina, I; Monteagudo, C, 2008) |
| "Cutaneous angiosarcoma is probably the most malignant neoplasm involving the skin." | 1.34 | Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma. ( Cerroni, L; Kaddu, S; Kutzner, H; Menzel, T; Requena, L; Santonja, C; Stutz, N; Weenig, RH, 2007) |
| "Scalp metastasis from breast carcinoma is reported but it is rare." | 1.33 | Multifocal scalp hair loss. ( Ebrahimi, H; Esfandiarpoor, I; Kalantari, B; Shamsadin, S; Zeinali, H, 2006) |
| "Brain metastases from breast cancer have a poor prognosis." | 1.33 | Letrozole for brain and scalp metastases from breast cancer--a case report. ( Bhatt, ML; Kirti, S; Kumar, S; Madhup, R; Srivastava, M; Srivastava, PK, 2006) |
| "Skeletal osteosarcoma is the most common primary malignant neoplasm of the bone, predominantly occurring in the metaphysis of the long bones of adolescents and young adults." | 1.32 | A case of extraskeletal osteosarcoma with metastasis to the skin. ( Covello, SP; Humphreys, TR; Lee, JB, 2003) |
| "The cutaneous pathology of Cowden's syndrome is characterized by multiple trichilemmomas." | 1.32 | Multiple inverted follicular keratoses as a presenting sign of Cowden's syndrome: case report with human papillomavirus studies. ( Nuovo, GJ; Ruhoy, SM; Thomas, D, 2004) |
| "All women with advanced breast cancer who are medically stable despite their disease are candidates for tumor extirpation and reconstruction." | 1.31 | Cranial reconstruction for metastatic breast cancer. ( Beck, CE; Harsh, G; Sieveking, NE; Turk, AE, 2000) |
| "A series of 35 breast cancer patients receiving adjuvant chemotherapy were consecutively assigned either to a scalp cooling regimen (19 patients) or to an ambient temperature regimen (16 patients)." | 1.30 | Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. ( Chaitchik, S; Inbar, M; Kalmus, Y; Kalmus, Z; Ron, IG, 1997) |
| "The percent of hair loss was rated at each visit and photographs were used to further quantitate any hair loss." | 1.27 | Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia. ( Cetas, TC; Dean, JC; Griffith, KS; Jones, SE; Mackel, CL; Salmon, SE, 1983) |
| "A patient with previously diagnosed Hodgkin's disease presented with ulcerating lesions on her scalp and breast." | 1.27 | Fine-needle aspiration biopsy of mycosis fungoides presenting as an ulcerating breast mass. ( Clark, EG; Schwartz, JG, 1988) |
| "For example, the metastatic seeds from breast carcinoma--the most common cause of secondary skin cancer--have an affinity for the anterior chest wall." | 1.26 | When primary cancer spreads to the skin. ( Kierland, RR; Klaus, SN, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (21.26) | 18.7374 |
| 1990's | 9 (5.17) | 18.2507 |
| 2000's | 30 (17.24) | 29.6817 |
| 2010's | 54 (31.03) | 24.3611 |
| 2020's | 44 (25.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseinzadeh, R | 2 |
| Khorsandi, K | 2 |
| Jahanshiri, M | 1 |
| Chamani, E | 1 |
| Hosseinzadeh, G | 1 |
| Ferreira, E | 1 |
| Cronjé, MJ | 1 |
| Renehan, S | 1 |
| Tencic, M | 1 |
| Jackson, K | 1 |
| Krishnasamy, M | 1 |
| Keim, S | 1 |
| Hempel, L | 1 |
| Ebner, F | 1 |
| Retzer-Lidl, M | 1 |
| Wohlmuth, K | 1 |
| Hempel, D | 1 |
| Milani, V | 1 |
| Yin, L | 1 |
| Klein, EJ | 1 |
| Svigos, K | 1 |
| Novice, T | 2 |
| Gutierrez, D | 1 |
| Oratz, R | 1 |
| Lacouture, ME | 2 |
| Powers, M | 1 |
| Senna, M | 1 |
| Shapiro, J | 1 |
| Lo Sicco, K | 1 |
| Chen, L | 1 |
| Xu, Y | 1 |
| Ye, X | 1 |
| Lugtenberg, RT | 1 |
| van den Hurk, CJG | 4 |
| Smorenburg, CH | 3 |
| Mosch, L | 1 |
| Houtsma, D | 1 |
| Deursen, MAGDH | 1 |
| Kaptein, AA | 1 |
| Gelderblom, H | 1 |
| Kroep, JR | 1 |
| Amarillo, D | 1 |
| de Boni, D | 1 |
| Cuello, M | 1 |
| Brunner, C | 1 |
| Emmelheinz, M | 1 |
| Kofler, R | 1 |
| Abdel Azim, S | 1 |
| Lehmann, M | 1 |
| Wieser, V | 1 |
| Ritter, M | 1 |
| Oberguggenberger, A | 1 |
| Marth, C | 1 |
| Egle, D | 1 |
| Hou, C | 1 |
| Xu, CJ | 1 |
| Li, MX | 1 |
| Xuan, JQ | 1 |
| Zhang, XY | 1 |
| Yang, KL | 1 |
| Liu, WQ | 1 |
| Huang, J | 1 |
| Ning, N | 1 |
| Novice, M | 1 |
| Portney, D | 1 |
| Goyert, J | 1 |
| Henry, NL | 1 |
| Jeruss, JS | 1 |
| Burness, ML | 1 |
| Carbognin, L | 1 |
| Accetta, C | 1 |
| Di Giorgio, D | 1 |
| Fuso, P | 1 |
| Muratore, M | 1 |
| Tiberi, G | 1 |
| Pavese, F | 1 |
| D'Angelo, T | 1 |
| Fabi, A | 1 |
| Giannarelli, D | 1 |
| Di Leone, A | 1 |
| Magno, S | 1 |
| Garganese, G | 1 |
| Sanchez, AM | 1 |
| Terribile, DA | 1 |
| Franceschini, G | 1 |
| Masetti, R | 1 |
| Scambia, G | 1 |
| Paris, I | 1 |
| Delgado Rodríguez, J | 1 |
| Ramos-García, V | 1 |
| Infante-Ventura, D | 2 |
| Suarez-Herrera, JC | 1 |
| Rueda-Domínguez, A | 1 |
| Serrano-Aguilar, P | 2 |
| Del Mar Trujillo-Martín, M | 1 |
| Rose, L | 1 |
| Schnell, PM | 1 |
| Radcliff, L | 1 |
| Lustberg, M | 1 |
| Dulmage, B | 1 |
| Regmi, A | 1 |
| Raouf, M | 1 |
| Mudaliar, KM | 1 |
| Speiser, JJ | 1 |
| Ananthanarayanan, V | 1 |
| Nomizu, T | 1 |
| Ueo, H | 1 |
| Kato, M | 1 |
| Fukuma, E | 1 |
| Trujillo-Martín, MM | 1 |
| de Armas-Castellano, A | 1 |
| González-Hernández, Y | 1 |
| González-Pacheco, H | 1 |
| Del Pino-Sedeño, T | 1 |
| Ramallo-Fariña, Y | 1 |
| Abt-Sack, A | 1 |
| Rueda Domínguez, A | 1 |
| Heibloem, RE | 1 |
| Komen, MMC | 3 |
| Ilozumba, OUC | 1 |
| Pleasant, VA | 1 |
| Purkiss, AS | 1 |
| Merjaver, SD | 1 |
| Abdulraheem, AM | 1 |
| Naji, D | 1 |
| Al Heyasat, AN | 1 |
| Alhasan, M | 1 |
| Almasri, NM | 1 |
| Odeh, R | 1 |
| Landeiro, LCG | 1 |
| Lopes Paim Miranda, D | 1 |
| Mathias Machado, R | 1 |
| Dienstmann, R | 1 |
| Costa E Silva, M | 1 |
| da Silva, CF | 1 |
| de Castro, ALR | 1 |
| Dos Santos, APT | 1 |
| Bomfim, VHV | 1 |
| Teixeira Machado, B | 1 |
| Viviane Carvalho Rodrigues Gonçalves, M | 1 |
| Freitas Muniz Teixeira, A | 1 |
| Jamile Santiago Costa, M | 1 |
| de Oliveira Dantas Viana, P | 1 |
| Almeida, P | 1 |
| de Cerqueira Mathias, CM | 1 |
| Wu, CX | 1 |
| Li, CH | 1 |
| Shiao, YH | 1 |
| Cheng, HY | 1 |
| Wu, TH | 1 |
| Lee, CH | 1 |
| Chang, ZY | 1 |
| Yeh, YC | 1 |
| Merrill, AL | 1 |
| Smith, SM | 1 |
| Peters, SB | 1 |
| Agnese, DM | 1 |
| Choi, Y | 1 |
| Jeong, YJ | 2 |
| Jeon, JG | 1 |
| Park, SH | 2 |
| Choi, HR | 1 |
| Kim, JK | 2 |
| Kako, J | 1 |
| Kajiwara, K | 1 |
| Kobayashi, M | 1 |
| Oosono, Y | 1 |
| Munzone, E | 2 |
| Pagan, E | 2 |
| Bagnardi, V | 2 |
| Mazzocco, K | 2 |
| Giarratano, T | 1 |
| Frezzini, S | 1 |
| Zanocco, M | 1 |
| Giorgi, CA | 1 |
| Mioranza, E | 1 |
| Miglietta, F | 1 |
| Griguolo, G | 1 |
| Falci, C | 1 |
| Faggioni, G | 1 |
| Tasca, G | 1 |
| Di Liso, E | 1 |
| Vernaci, G | 1 |
| Menichetti, A | 1 |
| Mantiero, M | 1 |
| Grosso, D | 1 |
| Guarneri, V | 1 |
| Dieci, MV | 1 |
| Bajpai, J | 2 |
| Kagwade, S | 1 |
| Chandrasekharan, A | 1 |
| Dandekar, S | 1 |
| Kanan, S | 1 |
| Kembhavi, Y | 1 |
| Ghosh, J | 1 |
| Banavali, SD | 1 |
| Gupta, S | 2 |
| Strait, AM | 1 |
| LeBlanc, RE | 1 |
| Muller, KE | 1 |
| Liu, YF | 1 |
| Liu, LY | 1 |
| Xia, SL | 1 |
| Li, T | 1 |
| Li, J | 1 |
| Patel, A | 1 |
| Kannan, S | 1 |
| Moonen, HPFX | 1 |
| Koot, RAC | 1 |
| Hoven-Gondrie, ML | 1 |
| Maguire, M | 1 |
| Drumm, C | 1 |
| Woods, G | 1 |
| Mullally, W | 1 |
| Redmond, M | 1 |
| Grogan, L | 1 |
| O'Kane, M | 1 |
| Ohsumi, S | 2 |
| Kiyoto, S | 2 |
| Takahashi, M | 2 |
| Hara, F | 1 |
| Takashima, S | 2 |
| Aogi, K | 2 |
| Matsuda, M | 1 |
| Yamamura, N | 1 |
| Doi, M | 2 |
| Caro, G | 1 |
| Fortuna, MC | 1 |
| Magri, F | 1 |
| Federico, A | 1 |
| Carlesimo, M | 1 |
| Rossi, A | 1 |
| Singer, S | 1 |
| Tkachenko, E | 1 |
| Sharma, P | 1 |
| Nelson, C | 1 |
| Mostaghimi, A | 1 |
| LeBoeuf, NR | 1 |
| Altundag, K | 1 |
| Araoye, EF | 1 |
| Stearns, V | 1 |
| Aguh, C | 1 |
| Fujii, T | 1 |
| Ichiba, K | 1 |
| Honda, C | 1 |
| Tokuda, S | 1 |
| Nakazawa, Y | 1 |
| Ogino, M | 1 |
| Kurozumi, S | 1 |
| Obayashi, S | 1 |
| Yajima, R | 1 |
| Shirabe, K | 1 |
| Pedersini, R | 1 |
| Fornaro, C | 1 |
| di Mauro, P | 1 |
| Bianchi, S | 1 |
| Vassalli, L | 1 |
| Amoroso, V | 1 |
| Gelmi, M | 1 |
| Ardine, M | 1 |
| Rodella, F | 1 |
| Cosentini, D | 1 |
| Dalla Volta, A | 1 |
| Turla, A | 1 |
| Pierini, M | 1 |
| Motta, P | 1 |
| Conti, E | 1 |
| Simoncini, EL | 1 |
| Berruti, A | 1 |
| Villarreal-Garza, C | 1 |
| Mesa-Chavez, F | 1 |
| Garza-Ledezma, MRA | 1 |
| Peña-Curiel, O | 1 |
| Martinez-Cannon, BA | 1 |
| Canavati-Marcos, M | 1 |
| Cardona-Huerta, S | 1 |
| Dilawari, A | 1 |
| Gallagher, C | 1 |
| Alintah, P | 1 |
| Chitalia, A | 1 |
| Tiwari, S | 1 |
| Paxman, R | 2 |
| Adams-Campbell, L | 1 |
| Dash, C | 1 |
| Usseglio, J | 1 |
| Pagès, E | 1 |
| Guyot, A | 1 |
| Laloze, J | 1 |
| Ferri, J | 1 |
| Shimizu, S | 1 |
| Wang, S | 1 |
| Yang, T | 1 |
| Shen, A | 1 |
| Qiang, W | 1 |
| Zhao, Z | 1 |
| Zhang, F | 1 |
| Chanihoon, GQ | 1 |
| Afridi, HI | 2 |
| Talpur, FN | 1 |
| Kazi, TG | 2 |
| Baig, JA | 1 |
| Ross, M | 2 |
| Fischer-Cartlidge, E | 2 |
| Ouédraogo Nde, NA | 1 |
| Ouédraogo, NA | 1 |
| Bambara, HA | 1 |
| Tiemtoré-Kambou, BM | 1 |
| Traoré, F | 1 |
| Zongo, N | 1 |
| Ouédraogo, MS | 1 |
| Tapsoba, GP | 1 |
| Thouraya Chtioui, A | 1 |
| Lamien/Sanou, A | 1 |
| Lim, JH | 1 |
| Siow, WS | 1 |
| Tan, LS | 1 |
| Moreno-Arrones, OM | 1 |
| Saceda-Corralo, D | 1 |
| Vañó-Galván, S | 1 |
| Makhija, M | 1 |
| Gorji, M | 1 |
| Kube, M | 1 |
| Rice, BA | 1 |
| Ver Hoeve, ES | 2 |
| DeLuca, AN | 1 |
| Esserman, LJ | 1 |
| Rugo, HS | 5 |
| Melisko, ME | 2 |
| Voigt, J | 2 |
| Murad, A | 1 |
| Bergfeld, W | 1 |
| Vasconcelos, I | 1 |
| Wiesske, A | 1 |
| Schoenegg, W | 1 |
| Chan, A | 1 |
| Bauwens, A | 1 |
| Pontre, S | 1 |
| Jackson, S | 1 |
| McGlone, F | 1 |
| Ernenwein, T | 1 |
| Chih, J | 1 |
| Reid, C | 1 |
| Nortier, JWR | 2 |
| van der Ploeg, T | 2 |
| Nieboer, P | 1 |
| van der Hoeven, JJM | 2 |
| Hernández, K | 1 |
| Featherstone, A | 1 |
| Haase, C | 1 |
| Smetanay, K | 1 |
| Junio, P | 1 |
| Feißt, M | 1 |
| Seitz, J | 1 |
| Hassel, JC | 1 |
| Mayer, L | 1 |
| Matthies, LM | 1 |
| Schumann, A | 1 |
| Hennigs, A | 1 |
| Heil, J | 1 |
| Sohn, C | 1 |
| Jaeger, D | 1 |
| Schneeweiss, A | 1 |
| Marmé, F | 1 |
| Prochilo, T | 1 |
| Huscher, A | 1 |
| Andreis, F | 1 |
| Mirandola, M | 1 |
| Zaina, E | 1 |
| Pomentale, B | 1 |
| Pedrali, C | 1 |
| Zanotti, L | 1 |
| Mutti, S | 1 |
| Zaniboni, A | 1 |
| Watanabe, T | 1 |
| Yagata, H | 1 |
| Saito, M | 1 |
| Okada, H | 1 |
| Yajima, T | 1 |
| Tamai, N | 1 |
| Yoshida, Y | 1 |
| Takayama, T | 1 |
| Imai, H | 1 |
| Nozawa, K | 1 |
| Sangai, T | 1 |
| Yoshimura, A | 1 |
| Hasegawa, Y | 1 |
| Yamaguchi, T | 1 |
| Shimozuma, K | 1 |
| Ohashi, Y | 1 |
| Estébanez, A | 1 |
| Vázquez, B | 1 |
| Térradez, L | 1 |
| Monteagudo, C | 2 |
| Marks, DH | 1 |
| Okhovat, JP | 1 |
| Hagigeorges, D | 1 |
| Manatis-Lornell, AJ | 1 |
| Isakoff, SJ | 1 |
| Senna, MM | 1 |
| Park, KU | 1 |
| Lucci, A | 1 |
| Heery, M | 1 |
| Cohen, S | 1 |
| Mena, Z | 1 |
| Campennì, G | 1 |
| Tramacere, A | 1 |
| Masiero, M | 1 |
| Iorfida, M | 1 |
| Mazza, M | 1 |
| Montagna, E | 1 |
| Cancello, G | 1 |
| Bianco, N | 1 |
| Palazzo, A | 1 |
| Cardillo, A | 1 |
| Dellapasqua, S | 1 |
| Sangalli, C | 1 |
| Pettini, G | 1 |
| Pravettoni, G | 1 |
| Colleoni, M | 1 |
| Veronesi, P | 1 |
| van den Hurk, CJ | 4 |
| van de Poll-Franse, LV | 1 |
| Breed, WP | 5 |
| Coebergh, JW | 1 |
| Nortier, JW | 2 |
| Lemieux, J | 4 |
| Provencher, L | 2 |
| Laflamme, C | 1 |
| Cigler, T | 2 |
| Isseroff, D | 1 |
| Fiederlein, B | 1 |
| Schneider, S | 1 |
| Chuang, E | 1 |
| Vahdat, L | 1 |
| Moore, A | 2 |
| Van Dorpe, J | 1 |
| Hoorens, A | 1 |
| Van Roy, N | 1 |
| Dedeurwaerdere, F | 1 |
| Creytens, D | 1 |
| Han, SM | 1 |
| Chikawa, J | 1 |
| Jeon, JK | 1 |
| Hwang, MY | 1 |
| Lim, J | 1 |
| Kim, HT | 1 |
| Jheon, S | 1 |
| Little, AJ | 1 |
| Seline, AE | 1 |
| Swick, BL | 1 |
| Wanat, KA | 1 |
| Shaw, J | 1 |
| Baylock, B | 1 |
| O'Reilly, A | 1 |
| Winstanley, J | 1 |
| Pugliano, L | 1 |
| Andrews, K | 1 |
| Boyle, F | 1 |
| Guida, M | 1 |
| Campana, LG | 1 |
| Curatolo, P | 1 |
| Strippoli, S | 1 |
| Bonadies, A | 1 |
| Grilz, G | 1 |
| Cabula, C | 1 |
| Rotunno, R | 1 |
| Bucher, S | 1 |
| Solari, N | 1 |
| Santoriello, A | 1 |
| Valpione, S | 1 |
| Rossi, CR | 1 |
| Sofianos, C | 1 |
| Chauke, NY | 1 |
| Grubnik, A | 1 |
| West, HJ | 1 |
| Hershman, DL | 1 |
| Nangia, J | 1 |
| Wang, T | 1 |
| Osborne, C | 1 |
| Niravath, P | 1 |
| Otte, K | 1 |
| Papish, S | 1 |
| Holmes, F | 1 |
| Abraham, J | 1 |
| Lacouture, M | 1 |
| Courtright, J | 1 |
| Rude, M | 1 |
| Hilsenbeck, S | 1 |
| Osborne, CK | 1 |
| Rimawi, M | 1 |
| Klein, P | 1 |
| Melin, SA | 2 |
| Hurvitz, SA | 1 |
| Park, G | 1 |
| Mitchel, J | 1 |
| Bågeman, E | 1 |
| D'Agostino, RB | 1 |
| Esserman, L | 1 |
| Muth, CC | 1 |
| Brower, V | 1 |
| Mols, F | 2 |
| Vingerhoets, AJ | 2 |
| Soma, PF | 1 |
| Chibbaro, S | 1 |
| Makiese, O | 1 |
| Marsella, M | 1 |
| Diemidio, P | 1 |
| Fricia, M | 1 |
| Passanisi, M | 1 |
| Catania, V | 1 |
| Siragò, P | 1 |
| Ventura, F | 1 |
| Penel, N | 1 |
| Bui, BN | 1 |
| Bay, JO | 1 |
| Cupissol, D | 1 |
| Ray-Coquard, I | 1 |
| Piperno-Neumann, S | 1 |
| Kerbrat, P | 1 |
| Fournier, C | 1 |
| Taieb, S | 1 |
| Jimenez, M | 1 |
| Isambert, N | 1 |
| Peyrade, F | 1 |
| Chevreau, C | 1 |
| Bompas, E | 1 |
| Brain, EG | 1 |
| Blay, JY | 1 |
| Martí, N | 1 |
| Molina, I | 1 |
| López, V | 1 |
| García, L | 1 |
| Jordá, E | 1 |
| Amireault, C | 1 |
| Maunsell, E | 1 |
| Conner, KB | 1 |
| Cohen, PR | 1 |
| Braverman, AS | 1 |
| Levy, G | 1 |
| Finkelstein, A | 1 |
| McNiff, JM | 1 |
| Aragó, P | 1 |
| Buch, E | 1 |
| Herranz, T | 1 |
| Galán, A | 1 |
| Muñoz, M | 1 |
| van de Sande, MA | 1 |
| Greco, M | 1 |
| Vitagliano, T | 1 |
| Fiorillo, MA | 1 |
| Atzeni, M | 1 |
| Corona, A | 1 |
| Ribuffo, D | 1 |
| Desbiens, C | 1 |
| Hogue, JC | 1 |
| Kim, HK | 1 |
| Chung, KI | 1 |
| Park, BY | 1 |
| Bae, TH | 1 |
| Kim, WS | 1 |
| Lee, TJ | 1 |
| Kuwayama, T | 1 |
| Sato, T | 1 |
| Nakagawa, T | 1 |
| Sugimoto, H | 1 |
| Ishiba, T | 1 |
| Kubota, K | 1 |
| Sugihara, K | 1 |
| Zalaudek, I | 1 |
| Gomez-Moyano, E | 1 |
| Landi, C | 1 |
| Lova Navarro, M | 1 |
| Fernandez Ballesteros, MD | 1 |
| De Pace, B | 1 |
| Vera-Casaño, A | 1 |
| Piana, S | 1 |
| Mondal, SK | 1 |
| Sengupta, SG | 1 |
| Bhattacharya, S | 1 |
| Sinha, SK | 1 |
| Protière, C | 1 |
| Evans, K | 1 |
| Camerlo, J | 1 |
| d'Ingrado, MP | 1 |
| Macquart-Moulin, G | 1 |
| Viens, P | 1 |
| Maraninchi, D | 1 |
| Genre, D | 1 |
| Dobson, CM | 1 |
| Tagor, V | 1 |
| Myint, AS | 1 |
| Memon, A | 1 |
| Covello, SP | 1 |
| Humphreys, TR | 1 |
| Lee, JB | 1 |
| WEIDAUER, S | 1 |
| EMMRICH, G | 1 |
| VILANOVA, X | 1 |
| ROMAGUERA, C | 1 |
| GRIMALT, F | 1 |
| DOCHEV, BD | 1 |
| CASALA, AM | 1 |
| QUARANTA, A | 1 |
| BIANCHI, C | 1 |
| BIANCHI, O | 1 |
| MEHREGAN, AH | 1 |
| PINKUS, H | 1 |
| GREGORIE, HB | 1 |
| STEVENSON, TB | 1 |
| ROBERTSON, HC | 1 |
| WARD, JL | 1 |
| KORTING, GW | 1 |
| Massey, CS | 1 |
| Ruhoy, SM | 1 |
| Thomas, D | 1 |
| Nuovo, GJ | 1 |
| Sonntag, M | 1 |
| Reifenberger, J | 1 |
| Megahed, M | 1 |
| Schulte, KW | 1 |
| Haas, N | 1 |
| Hauptmann, S | 1 |
| Jennens, RR | 1 |
| Rosenthal, MA | 1 |
| Gonzales, M | 1 |
| Kilic, E | 1 |
| Saraymen, R | 1 |
| Demiroglu, A | 1 |
| Ok, E | 1 |
| Ammatuna, E | 1 |
| Borza, PA | 1 |
| Iori, AP | 1 |
| Petti, MC | 1 |
| Pescarmona, E | 1 |
| Diverio, D | 1 |
| Lo-Coco, F | 1 |
| Madhup, R | 1 |
| Kirti, S | 1 |
| Bhatt, ML | 1 |
| Srivastava, PK | 1 |
| Srivastava, M | 1 |
| Kumar, S | 1 |
| Scalise, A | 1 |
| Bertani, A | 1 |
| Forlini, W | 1 |
| Pierangeli, M | 1 |
| Piedimonte, A | 1 |
| Regev, E | 1 |
| Goldan, O | 1 |
| Orenstein, A | 1 |
| Winkler, E | 1 |
| Haik, J | 1 |
| Scheinfeld, N | 1 |
| Shamsadin, S | 1 |
| Esfandiarpoor, I | 1 |
| Zeinali, H | 1 |
| Kalantari, B | 1 |
| Ebrahimi, H | 1 |
| Memon, AU | 1 |
| Jamali, MK | 1 |
| Arain, MB | 1 |
| Jalbani, N | 1 |
| Syed, N | 1 |
| Karampelas, I | 1 |
| Cole, PM | 1 |
| Kuensting, JM | 1 |
| Fenstermaker, RA | 1 |
| Requena, L | 1 |
| Santonja, C | 1 |
| Stutz, N | 1 |
| Kaddu, S | 1 |
| Weenig, RH | 1 |
| Kutzner, H | 1 |
| Menzel, T | 1 |
| Cerroni, L | 1 |
| Prochno, T | 1 |
| Koch, S | 1 |
| Wohlfarth, B | 1 |
| Breiting, L | 1 |
| Dahlstrøm, K | 1 |
| Christensen, L | 1 |
| Winther, JF | 1 |
| Breiting, V | 1 |
| Gross, PR | 1 |
| Carter, DM | 1 |
| Nielsen, BB | 1 |
| Samonigg, H | 1 |
| Fereberger, W | 1 |
| Biffl, E | 1 |
| Martin, J | 1 |
| Ross, JB | 1 |
| Dean, JC | 1 |
| Griffith, KS | 1 |
| Cetas, TC | 1 |
| Mackel, CL | 1 |
| Jones, SE | 1 |
| Salmon, SE | 1 |
| Anderson, JE | 2 |
| Hunt, JM | 2 |
| Smith, IE | 2 |
| Gregory, RP | 1 |
| Cooke, T | 1 |
| Middleton, J | 2 |
| Buchanan, RB | 2 |
| Williams, CJ | 2 |
| Belpomme, D | 1 |
| Mignot, L | 1 |
| Grandjean, M | 1 |
| Pujade-Lauraine, E | 1 |
| Le Rol, A | 1 |
| Gisselbrecht, C | 1 |
| Marty, M | 1 |
| Boiron, M | 1 |
| Maddox, JC | 1 |
| Evans, HL | 1 |
| Baum, EM | 1 |
| Omura, EF | 1 |
| Payne, RR | 1 |
| Little, WP | 1 |
| Barzó, P | 1 |
| Molnár, L | 1 |
| Tóth, E | 1 |
| Presser, SE | 1 |
| Christeler, A | 1 |
| Tollenaar, RA | 1 |
| Liefers, GJ | 1 |
| Repelaer van Driel, OJ | 1 |
| van de Velde, CJ | 1 |
| Mallon, E | 1 |
| Dawber, RP | 1 |
| Carson, HJ | 1 |
| Pellettiere, EV | 1 |
| Lack, E | 1 |
| Vilmer, C | 1 |
| Trassard, M | 1 |
| Ron, IG | 1 |
| Kalmus, Y | 1 |
| Kalmus, Z | 1 |
| Inbar, M | 1 |
| Chaitchik, S | 1 |
| Möhrenschlager, M | 1 |
| Graefe, C | 1 |
| Abeck, D | 1 |
| Ring, J | 1 |
| Sieveking, NE | 1 |
| Turk, AE | 1 |
| Beck, CE | 1 |
| Harsh, G | 1 |
| Meyer, P | 1 |
| James, VJ | 1 |
| Chang, CC | 1 |
| Somach, SC | 1 |
| Edelstyn, GA | 1 |
| MacDonald, M | 1 |
| MacRae, KD | 1 |
| Klaus, SN | 1 |
| Kierland, RR | 1 |
| Hillen, HF | 1 |
| Botman, CJ | 1 |
| Velez, JR | 1 |
| Ferrando, J | 1 |
| Palou, J | 1 |
| Mascaro, JM | 1 |
| Archer, CB | 1 |
| Smith, NP | 1 |
| Konishi, Y | 1 |
| Kuroki, T | 1 |
| Schwartz, JG | 1 |
| Clark, EG | 1 |
| Barax, CN | 1 |
| Lebwohl, M | 1 |
| Phelps, RG | 1 |
| Chaoui, A | 1 |
| Achour, M | 1 |
| Bakkali, KA | 1 |
| Oudghiri, A | 1 |
| Saoura, A | 1 |
| Kharbach, A | 1 |
| Franks, D | 1 |
| Hall, V | 1 |
| Smallwood, J | 1 |
| Miller, JL | 1 |
| Okun, MR | 1 |
| Di Mattia, A | 1 |
| Thompson, J | 1 |
| Pearson, SH | 1 |
| Brownstein, MH | 1 |
| Helwig, EB | 1 |
| Shrikhande, SS | 1 |
| Sirsat, MV | 1 |
| Friedmann, E | 1 |
| Thiers, H | 2 |
| Moulin, G | 2 |
| Perrot, H | 2 |
| Reed, JC | 1 |
| Das Gupta, TK | 1 |
| Brasfield, RD | 1 |
| Strong, EW | 1 |
| Hajdu, SI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Multi-centre Trial to Evaluate Effectiveness of 45-min and 20-min Post-infusion Cooling Time for Patients Treated With Scalp Cooling to Prevent Paclitaxel-induced Alopecia[NCT03266185] | 91 participants (Actual) | Interventional | 2017-12-20 | Completed | |||
| Measuring the Efficacy of Paxman Scalp Cooling to Prevent Chemotherapy Induced Alopecia (CIA) in Black Patients With Stage I-III Breast or Gynecological Cancers[NCT04626895] | 15 participants (Actual) | Interventional | 2019-06-04 | Completed | |||
| The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer[NCT04558034] | 14 participants (Actual) | Interventional | 2020-08-04 | Terminated (stopped due to Principal Investigator retired before study completed.) | |||
| A Study on the Efficacy and Safety of DIGNICAP™ System for Preventing Chemotherapy Induced Alopecia[NCT03712696] | 139 participants (Actual) | Interventional | 2014-07-18 | Completed | |||
| A Randomized Controlled Trial to Evaluate Effectiveness of Cooling Cap to Prevent Permanent Chemotherapy-induced Alopecia Among Breast Cancer Patients[NCT04678544] | 170 participants (Actual) | Interventional | 2020-12-23 | Completed | |||
| Scalp Cooling for Alopecia Prevention (SCALP)[NCT01986140] | 236 participants (Actual) | Interventional | 2014-05-15 | Active, not recruiting | |||
| Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer[NCT01831024] | 110 participants (Anticipated) | Interventional | 2013-07-31 | Active, not recruiting | |||
| Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery[NCT00217607] | Phase 2 | 30 participants (Actual) | Interventional | 2005-02-28 | Completed | ||
| A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres.[NCT00390377] | Phase 2 | 240 participants | Interventional | 2006-10-31 | Recruiting | ||
| A Prospective Blinded Study to Evaluate and Characterise an Assay for the Diagnosis of Breast Cancer Using Synchrotron-Derived X-Ray Diffraction of Hair Fibres.[NCT00419679] | Phase 1/Phase 2 | 3,600 participants | Interventional | 2006-12-31 | Recruiting | ||
| [NCT00419900] | Phase 1/Phase 2 | 2,000 participants | Interventional | 2006-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for salicylic acid and Breast Neoplasms
| Article | Year |
|---|---|
Chemotherapy, Alopecia, and Scalp Cooling Systems.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Communication; Female; Humans; Scalp | 2023 |
[Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.]
Topics: Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Quality of | 2023 |
The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis.
Topics: Alopecia; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Hypothermia, Induced; Scalp | 2021 |
Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hypother | 2018 |
5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Breast Neoplasms; Depression; Dutasteride; Evidence-Based Me | 2018 |
Asymptomatic erythematous hardened plaque on the scalp.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Eccrine Glands; Head and Neck Neoplasms; Humans; Ma | 2020 |
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Topics: Alopecia; Breast Neoplasms; Bridged-Ring Compounds; Cryotherapy; Female; Humans; Induction Chemother | 2019 |
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cryotherapy; Female; Head | 2017 |
Rare malignant tumors of the scalp: a report of four cases, their treatment and a review of the literature.
Topics: Aged; Breast Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Melanoma; Scalp; Sk | 2010 |
Metastatic myoepithelioma of the breast.
Topics: Aged; Breast Neoplasms; Cell Transformation, Neoplastic; Female; Head and Neck Neoplasms; Humans; Ki | 2004 |
Review of scalp alopecia due to a clinically unapparent or minimally apparent neoplasm (SACUMAN).
Topics: Alopecia; Breast Neoplasms; Carcinoma, Basal Cell; Cicatrix; Hemangiosarcoma; Humans; Keloid; Lympho | 2006 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 1994 |
Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma.
Topics: Adult; Alopecia; Alopecia Areata; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Scalp; | 1994 |
[Multiple cancers. Apropos of a quadruple cancer].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Middle Aged; Neop | 1985 |
18 trials available for salicylic acid and Breast Neoplasms
| Article | Year |
|---|---|
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2023 |
Electric hand warmer versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia prevention: a randomized study.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Middle Aged | 2023 |
The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial.
Topics: Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Head Protective Devices; Humans; Lo | 2023 |
"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Topics: Adult; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Ch | 2020 |
Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Animals; Breast Neoplasms; Carboplatin; Docetaxel; Female; | 2018 |
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 2019 |
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2019 |
Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cryotherapy | 2019 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compoun | 2017 |
Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Body Image; Breast Neoplasms; Female; Huma | 2009 |
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Su | 2008 |
Impact of alopecia and scalp cooling on the well-being of breast cancer patients.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Anxiety Disorders; Body Image; Breast Neop | 2010 |
Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 2002 |
A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Midd | 2004 |
[Prevention of chemotherapy-induced alopecia in cancer patients by scalp hypothermia (author's transl)].
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combinati | 1982 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherap | 1994 |
Doxorubicin-induced hair loss and possible modification by scalp cooling.
Topics: Alopecia; Breast Neoplasms; Cryotherapy; Doxorubicin; Female; Humans; Scalp | 1977 |
142 other studies available for salicylic acid and Breast Neoplasms
| Article | Year |
|---|---|
Combination photodynamic therapy of human breast cancer using salicylic acid and methylene blue.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Humans; Methylene Blue; Ph | 2017 |
Comparative study of photodynamic activity of methylene blue in the presence of salicylic acid and curcumin phenolic compounds on human breast cancer.
Topics: Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Shape; Cell Survival; Curcumin; Fema | 2019 |
Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells.
Topics: 14-3-3 Proteins; Actins; Analysis of Variance; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female | 2012 |
Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2022 |
Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
Topics: Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2022 |
Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2023 |
Low temperature mitigating the paclitaxel-induced damages in mouse cell and hair follicle model.
Topics: Alopecia; Animals; Antineoplastic Agents; Breast Neoplasms; Female; Hair Follicle; Humans; Hypotherm | 2022 |
Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Irregular treatment leading to pituitary and scalp involvement in metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Pituitary Diseases; Pituitary Gland; Scalp; Skin Neoplasms | 2022 |
Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Scalp | 2022 |
Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2022 |
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Topics: Adult; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2022 |
Retrospective cohort study of scalp cooling in breast cancer patients.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2023 |
Primary Cutaneous Ewing Sarcoma of the Scalp With Metastasis to the Lung: An Unusual Manifestation During Pregnancy.
Topics: Adult; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Delayed Diagnosis; Female; Humans; Lung; | 2023 |
[Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2023 |
Redefining the "crown": Approaching chemotherapy-induced alopecia among Black patients with breast cancer.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African Am | 2023 |
Breast cancer with scalp metastases: a case report.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Mastectomy; Melanoma, Cutaneous Maligna | 2023 |
Eccrine carcinoma masquerading as metastatic breast cancer.
Topics: Adenocarcinoma, Mucinous; Aged; Axilla; Breast Neoplasms; Diagnosis, Differential; Female; Head and | 2020 |
Medulla loss of scalp hair in breast cancer patients determined by near-infrared microscopy.
Topics: Adult; Aged; Breast Neoplasms; Equipment Design; Female; Hair; Humans; Microscopy; Middle Aged; Scal | 2019 |
Comment on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines".
Topics: Alopecia; Anthracyclines; Breast Neoplasms; Humans; Prospective Studies; Scalp | 2019 |
Reply to Comments on: "Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines."
Topics: Alopecia; Anthracyclines; Breast Neoplasms; Humans; Prospective Studies; Scalp | 2019 |
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hypother | 2020 |
Proliferating pilar tumor: a rare cutaneous entity mimicking breast malignancy on imaging.
Topics: Breast Neoplasms; Epidermal Cyst; Female; Hair Diseases; Humans; Scalp; Skin Neoplasms | 2020 |
An Unusual Case of Scalp Metastasis from Breast Cancer.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Humans; Immunohistochemistry; Mastectomy; Middle Aged; Neu | 2020 |
Study validity depends on the study design and bias. Comment on "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia" by Bajpai et al. (The Breast. 2019 December 12. Doi: 10.1016/j.breast.2019.12.004 [Epub ahea
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Scalp; Taxoids | 2020 |
Correspondence in response to the letter "Study validity depends on the study design and bias. Comment on "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Scalp; Taxoids | 2020 |
[Eccrine carcinoma: a diagnostic pitfall].
Topics: Aged; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Humans; Neoplasm Recurrence, Loc | 2020 |
A case of delayed-onset scarring alopecia in a 75-year-old woman.
Topics: Aged; Alopecia; Anastrozole; Aromatase Inhibitors; Biopsy; Bone Density Conservation Agents; Breast | 2020 |
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hum | 2021 |
A new treatment of alopecia induced by palbociclib: Topical cetirizine.
Topics: Administration, Topical; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cetirizine; Cyclin | 2021 |
Geographic disparities in access to scalp cooling for the prevention of chemotherapy-induced alopecia in the United States.
Topics: Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2021 |
Probable association between increased systemic recurrence and the use of scalp cooling in breast cancer patients receiving (neo)adjuvant chemotherapy.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; | 2021 |
Considerations for the Use of Scalp Cooling Devices in Black Patients.
Topics: Alopecia; Black or African American; Breast Neoplasms; Female; Hair Follicle; Humans; Hypothermia, I | 2020 |
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Topics: Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 2021 |
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced | 2021 |
Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2021 |
Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African Am | 2021 |
Trichilemmal carcinoma of the scalp.
Topics: Aged, 80 and over; Breast Neoplasms; Carcinoma; Humans; Male; Neoplasms, Connective Tissue; Scalp; S | 2021 |
Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; | 2021 |
Interaction Between Essential (Zn) and Toxic (Cd) Elements in Different Stages of Female Breast Cancer Patients, Resident in Different Cities of Sindh, Pakistan.
Topics: Adult; Breast Neoplasms; Cadmium; Cities; Female; Humans; Pakistan; Scalp; Spectrophotometry, Atomic | 2022 |
Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia
.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Breast Neoplasms; Education, Nursin | 2017 |
Breast and pleuropulmonary metastasis of multirecurrent scalp dermatofibrosarcoma protuberans: a case report.
Topics: Adult; Alopecia; Antigens, CD34; Antineoplastic Agents; Biopsy; Breast Neoplasms; Cough; Dermatofibr | 2017 |
A case of multifocal scarring alopecia.
Topics: Alopecia; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cicatrix; Fatal Outcome; Fema | 2017 |
RF-Scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cryotherapy; | 2017 |
Mixed Tumor, Eccrine Type: So What If it's Vulval!
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Eccrine Glands; Female; Head and Neck Neoplasms; Hu | 2018 |
Real-world use of scalp cooling to reduce chemotherapy-related hair loss.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; F | 2017 |
Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Topics: Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2018 |
Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2018 |
Scalp Cooling: Implementation of a Program at a Multisite Organization.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 2018 |
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Hair; Humans; Mi | 2019 |
Nipple sparing mastectomy for melanoma metastatic to the breast.
Topics: Adult; Breast Implants; Breast Neoplasms; Female; Humans; Mammaplasty; Mastectomy, Subcutaneous; Mel | 2019 |
Scalp Cooling: Implementing a Cold Cap Program at a Community Breast Health Center.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Community Health Centers | 2019 |
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
Topics: Adult; Aged; Alopecia; Anthracyclines; Breast Neoplasms; Cold Temperature; Female; Humans; Middle Ag | 2019 |
Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cryotherapy; Female; Head and Neck Neoplasms; Hum | 2013 |
Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Canada; Data Collection; Female; Health Kn | 2014 |
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 2015 |
The challenging differential diagnosis of skin tumours with a rhabdoid phenotype: not all tumours with rhabdoid phenotype belong to the group of SMARCB1-deficient tumours.
Topics: Biomarkers, Tumor; Breast Neoplasms; Chromosomal Proteins, Non-Histone; Diagnosis, Differential; DNA | 2016 |
Synchrotron nanoscopy imaging study of scalp hair in breast cancer patients and healthy individuals: Difference in medulla loss and cortical membrane enhancements.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Hair; Humans; Middle Aged; Scalp; Synchrot | 2016 |
Cutaneous metastasis of breast adenoid cystic carcinoma to the scalp.
Topics: Aged; Breast Neoplasms; Carcinoma, Adenoid Cystic; Female; Head and Neck Neoplasms; Humans; Scalp; S | 2016 |
Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer.
Topics: Alopecia; Australia; Breast Neoplasms; Female; Focus Groups; Humans; Hypothermia, Induced; Perceptio | 2016 |
Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study.
Topics: Aged; Bleomycin; Breast Neoplasms; Electrochemotherapy; Female; Hemangiosarcoma; Humans; Male; Multi | 2016 |
Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2016 |
Metastatic trichilemmal carcinoma in a patient with breast cancer.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Adnexal and Sk | 2016 |
Do the Data on Scalp Cooling for Patients With Breast Cancer Warrant Broad Adoption?
Topics: Alopecia; Breast Neoplasms; Female; Humans; Scalp | 2017 |
Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Humans; Hypothermia, Induced; Induction Chemother | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 2017 |
Chemotherapy and Hair Loss.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Scalp | 2017 |
Scalp cooling and hair loss during breast cancer chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Clinical Trials, Phase III as Topic; Equipment De | 2017 |
Aggressive scalp carcinoma with intracranial extension: a multidisciplinary experience of 25 patients with long-term follow-up.
Topics: Aged; Breast Neoplasms; Carcinoma; Cranial Sinuses; Dura Mater; Female; Humans; Interdisciplinary Co | 2008 |
Cutaneous metastasis of breast carcinoma mimicking malignant melanoma in scalp.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Head and Neck Neoplasm | 2008 |
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, A | 2009 |
Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica.
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Risk Factors; Scalp; Skin N | 2009 |
Cutaneous metastases from breast cancer.
Topics: Alopecia; Breast Neoplasms; Female; Humans; Risk Factors; Scalp; Skin Neoplasms | 2009 |
Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Diagn | 2010 |
[Choroidal and scalp metastasis in breast cancer].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Choroid Neoplasms; Female; Head and Neck Neoplasms; Hum | 2010 |
[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur].
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2010 |
Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2011 |
Primary apocrine carcinoma of scalp: report of primary scalp cutaneous apocrine carcinoma indistinguishable from cutaneous metastasis of breast carcinoma.
Topics: Adenocarcinoma; Apocrine Glands; Breast Neoplasms; Carcinoma, Skin Appendage; Diagnosis, Differentia | 2012 |
[A case of scalp metastases from breast cancer successfully treated with letrozole].
Topics: Antineoplastic Agents; Biopsy; Breast Neoplasms; Female; Head and Neck Neoplasms; Humans; Letrozole; | 2011 |
Clinical, dermoscopic and histopathological features of spontaneous scalp or face and radiotherapy-induced angiosarcoma.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Dermoscopy; Facial Neoplasms; Female; Hemangiosarcoma; Hu | 2013 |
Reducing chemotherapy-induced alopecia with scalp cooling.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cold Temperature; Female; Humans; Hypothermia, In | 2012 |
Primary non-Hodgkin's lymphoma of breast with scalp involvement in follow-up--an uncommon presentation.
Topics: Biopsy; Biopsy, Fine-Needle; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Follow-Up St | 2012 |
Telangiectatic metastatic breast carcinoma in face and scalp mimicking cutaneous angiosarcoma.
Topics: Breast Neoplasms; Carcinoma; Diagnosis, Differential; Facial Neoplasms; Female; Hemangiosarcoma; Hum | 2003 |
A case of extraskeletal osteosarcoma with metastasis to the skin.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; O | 2003 |
[Dermatological case report of erysipeloid carcinoma].
Topics: Breast Neoplasms; Carcinoma; Erysipeloid; Humans; Medical Records; Neoplasms; Scalp | 1960 |
[Postmastectomy lethalities of the scalp simulating erythematodes].
Topics: Breast; Breast Neoplasms; Humans; Lupus Erythematosus, Systemic; Neoplasms; Scalp | 1959 |
[A case of primary multiple malignant tumor. (Carcinoma of the breast in a 42-year-old woman in conjunction with 2 other carcinomas].
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma; Carcinoma, Ductal; Carcinoma, Squamous Cell; Female; Hu | 1962 |
[METASTATIC CARCINOMA OF THE SCALP].
Topics: Breast Neoplasms; Carcinoma; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Scalp; Skin Neoplasm | 1963 |
INTRAEPIDERMAL EPITHELIOMA: A CRITICAL STUDY.
Topics: Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Classification; History; Humans; | 1964 |
PRELIMINARY OBSERVATIONS IN A CLINICAL STUDY OF HEMATOPORPHYRIN-DERIVATIVE FLUORESCENCE IN MALIGNANT NEOPLASMS.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Eye Neoplasms; Female; Fluorescenc | 1964 |
[Breast carcinoma metastases to the scalp with pigmented dendrite cells].
Topics: Breast Neoplasms; Carcinoma; Dendrites; Humans; Neoplasms; Scalp; Skin Neoplasms | 1962 |
Multiple inverted follicular keratoses as a presenting sign of Cowden's syndrome: case report with human papillomavirus studies.
Topics: Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Intraductal, Noninfiltrating; Darier Disease; DN | 2004 |
[Ulcus terebrans. Therapy options and their limits].
Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Moda | 2004 |
Alopecia neoplastica due to metastatic breast carcinoma vs. extramammary Paget's disease: mimicry in epidermotropic carcinoma.
Topics: Aged; Aged, 80 and over; Alopecia; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Different | 2004 |
Chromium and manganese levels in the scalp hair of normals and patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chromium; Female; Hair; Humans; Manganese; Middle Aged; Neoplasm Staging; S | 2004 |
Multiple relapses and extramedullary localization with scalp and breast involvement in a case of acute promyelocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Female; Human | 2005 |
Letrozole for brain and scalp metastases from breast cancer--a case report.
Topics: Aromatase Inhibitors; Brain Neoplasms; Breast Neoplasms; Female; Head and Neck Neoplasms; Humans; Le | 2006 |
Cutaneous angiosarcoma of the skin: three rare cases.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lymphatic | 2006 |
Permanent pressure alopecia after microsurgical breast reconstruction.
Topics: Alopecia; Breast Neoplasms; Equipment and Supplies, Hospital; Equipment Design; Female; Humans; Intr | 2006 |
Multifocal scalp hair loss.
Topics: Adult; Alopecia Areata; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Ca | 2006 |
Evaluation of zinc status in whole blood and scalp hair of female cancer patients.
Topics: Breast Neoplasms; Female; Hair; Humans; Ovarian Neoplasms; Scalp; Spectrophotometry, Atomic; Zinc | 2007 |
Diagnosis and conservative management of an arteriovenous fistula of the scalp following awake craniotomy for tumor resection.
Topics: Arterio-Arterial Fistula; Brain Neoplasms; Breast Neoplasms; Carcinoma; Carotid Artery Diseases; Cra | 2007 |
Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Endothelial Cells; Endothelium, Vascular; Facial Ne | 2007 |
[Scalp metastasis of unrecognized breast cancer].
Topics: Aged; Breast Neoplasms; Female; Head and Neck Neoplasms; Humans; Melanoma; Scalp; Skin Neoplasms | 2007 |
Primary mucinous carcinoma of the skin.
Topics: Adenocarcinoma, Mucinous; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Scalp; Sk | 2007 |
Malignant melanoma arising in a giant cerebriform nevus.
Topics: Breast Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mastectomy; Melanoma; Mid | 1967 |
Leiomyosarcoma of the breast with late dissemination.
Topics: Adult; Breast Neoplasms; Female; Humans; Leiomyosarcoma; Neoplasm Recurrence, Local; Scalp; Skin Neo | 1984 |
[Pneumatic cold cap for the prevention of doxorubicin-induced alopecia].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxoru | 1984 |
Alopecia totalis as a presentation of cutaneous metastasis (alopecia neoplastica).
Topics: Adenocarcinoma; Aged; Alopecia; Breast Neoplasms; Female; Humans; Scalp; Skin Neoplasms | 1983 |
Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-R | 1983 |
Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carcinoid Tumor; Doxorubicin; Female; Gels; Humans; Hypothe | 1981 |
Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.
Topics: Alopecia; Breast Neoplasms; Cryotherapy; Doxorubicin; Female; Humans; Scalp; Time Factors | 1982 |
Scalp hypothermia to prevent adriamycin-induced hair loss.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carcinoid Tumor; Doxorubicin; Female; Humans; Hypothermia, | 1982 |
Angiosarcoma of skin and soft tissue: a study of forty-four cases.
Topics: Adult; Aged; Arm; Axilla; Bone Marrow; Breast Neoplasms; Facial Neoplasms; Female; Head and Neck Neo | 1981 |
Alopecia neoplastica--a rare form of cutaneous metastasis.
Topics: Alopecia; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1981 |
[Prevention of alopecia, induced by cytostatic drugs, using hypothermia on the scalp].
Topics: Adult; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cryotherapy; Female; Humans; Lung Neoplasm | 1981 |
Prevention of doxorubicin-induced hair loss.
Topics: Breast Neoplasms; Doxorubicin; Female; Hair; Humans; Hypothermia, Induced; Neoplasm Metastasis; Scal | 1980 |
[Secondary tumors of the scalp].
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; | 1980 |
Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis.
Topics: Adenocarcinoma; Aged; Alopecia; Breast Neoplasms; Female; Humans; Scalp; Skin Neoplasms | 1994 |
[A case for diagnosis: cutaneous metastasis of breast carcinoma].
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1993 |
Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Case-Control Studies; Female; Humans; Hypothermia | 1997 |
Curly hair following radiotherapy epilation.
Topics: Brain Neoplasms; Breast Neoplasms; Female; Hair; Humans; Middle Aged; Scalp | 1998 |
Cranial reconstruction for metastatic breast cancer.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Frontal Bone; Humans; Middle Ag | 2000 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Hair; Humans; | 2001 |
Firm erythematous papules of scalp in a woman with a history of breast cancer.
Topics: Aged; Biopsy; Breast Neoplasms; Cell Nucleus; Cytoplasm; Female; Histiocytosis, Langerhans-Cell; Hum | 2001 |
When primary cancer spreads to the skin.
Topics: Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Gastrointestinal Neoplasms; Ge | 1976 |
Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Hypothermia, Induced; Scalp; Temp | 1990 |
[Metastatic alopecia].
Topics: Adenocarcinoma; Alopecia; Breast Neoplasms; Female; Humans; Middle Aged; Scalp; Skin Neoplasms | 1990 |
Alopecia neoplastica responsive to tamoxifen.
Topics: Alopecia; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Scalp; Skin Neoplasms; Tamoxifen | 1990 |
[Prevention of adriamycin-induced alopecia by scalp hypothermia with a deep-frozen Duncool-Cap].
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Doxorubicin; Female; Freezing; Humans; Hypothermia, Induced | 1988 |
Fine-needle aspiration biopsy of mycosis fungoides presenting as an ulcerating breast mass.
Topics: Adult; Biopsy, Needle; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Hodgkin Disease; H | 1988 |
Multiple hamartoma syndrome.
Topics: Adolescent; Breast; Breast Neoplasms; Carcinoma in Situ; Female; Fibrocystic Breast Disease; Hamarto | 1987 |
Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
Topics: Alopecia; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation | 1985 |
Metastatic carcinoma of the scalp.
Topics: Adenocarcinoma, Mucinous; Breast Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiothe | 1970 |
Malignant melanoma developing from intradermal nevi.
Topics: Breast Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nevus, Pigmented | 1974 |
Patterns of cutaneous metastasis.
Topics: Abdomen; Adult; Age Factors; Aged; Back; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Fema | 1972 |
Primary osteogenic sarcoma of the breast. (A case report).
Topics: Adult; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Osteosarcoma; Scalp | 1971 |
[Metastatic epithelioma of the scalp, probably of mammary origin; primary infiltrating alopecic type].
Topics: Adult; Alopecia; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Scalp; Skin Neoplasms | 1969 |
[Cephalic cutaneous metastasis 20 years after a cancer of the breast].
Topics: Aged; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Scalp; Skin Neoplasms | 1967 |
[Cephalic cutaneous metastasis 20 years after cancer of the breast].
Topics: Aged; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Scalp; Skin Neoplasms | 1967 |
Nevoid basal cell carcinoma syndrome with associated fibrosarcoma of the maxilla. Report of a case.
Topics: Adenoma; Adult; Biopsy; Breast Neoplasms; Carcinoma; Epithelium; Facial Neoplasms; Female; Head and | 1968 |
Benign solitary Schwannomas (neurilemomas).
Topics: Adolescent; Adult; Aged; Arm; Breast Neoplasms; Cheek; Child; Child, Preschool; Facial Neoplasms; Fe | 1969 |